コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 as an interacting partner for IAV HA through mass spectrometry analysis.
2 verified it with chemical cross-linking and mass spectrometry analysis.
3 ous food samples prior to gas chromatography-mass spectrometry analysis.
4 ommon electrospray ionization time-of-flight mass spectrometry analysis.
5 digestion model combined to high resolution mass spectrometry analysis.
6 Hall effect and time-of-flight secondary ion mass spectrometry analysis.
7 ed through oxidation reactions of Trolox via mass spectrometry analysis.
8 uctural information available through native mass spectrometry analysis.
9 ed by affinity purification and quantitative mass spectrometry analysis.
10 ward their protein targets in vitro based on mass spectrometry analysis.
11 nsuming using traditional gas chromatography mass spectrometry analysis.
12 and liquid chromatography coupled to tandem mass spectrometry analysis.
13 urification time from 3.5 h to 30 min before mass spectrometry analysis.
14 cid content obtained from gas chromatography-mass spectrometry analysis.
15 en bromide cleavage to facilitate subsequent mass spectrometry analysis.
16 and enabled compatible sample processing for mass spectrometry analysis.
17 on and nanoflow liquid chromatography-tandem mass spectrometry analysis.
18 k of UV detection and as a result a need for mass spectrometry analysis.
19 on the basis of pyrolysis-gas chromatography/mass spectrometry analysis.
20 complex in planta by immunoprecipitation and mass spectrometry analysis.
21 ction and dissociation prior to ion mobility/mass spectrometry analysis.
22 leasing from glycoproteins/glycopeptides for mass spectrometry analysis.
23 ctionate the complex protein extracts before mass spectrometry analysis.
24 1 using chemical cross-linking combined with mass spectrometry analysis.
25 of the sea star, and identified dysferlin by mass spectrometry analysis.
26 ve fluorophotometry, electron microscopy and mass spectrometry analysis.
27 wise gradient elution and electrosprayed for mass spectrometry analysis.
28 h pressure using label-free quantitation and mass spectrometry analysis.
29 d VOCs were determined by gas chromatography-mass spectrometry analysis.
30 mented mice were characterized by lipidomics mass spectrometry analysis.
31 ts, demonstrating complementary detection by mass spectrometry analysis.
32 labeling and click chemistry with subsequent mass spectrometry analysis.
33 suspensions were analyzed by time of flight mass spectrometry analysis.
34 ormed via data-independent acquisition (DIA) mass spectrometry analysis.
35 es) prior to their gas chromatography tandem mass spectrometry analysis.
36 tification with liquid chromatography tandem mass spectrometry analysis.
37 nfirmation of their nuclear origin shown via mass spectrometry analysis.
38 her normal tissues, as determined by in vivo mass spectrometry analysis.
39 bulin as was observed by electrophoresis and mass spectrometry analysis.
40 studies, mass analysis, and high-resolution mass spectrometry analysis.
41 plex mixture (UCM) during gas-chromatography mass-spectrometry analysis.
42 id chromatography (UHPLC) and time-of-flight mass spectrometry analysis, allowing the acquisition of
45 rat brain utilizing immunohistochemistry and mass spectrometry analysis and assessed the effect of ag
48 how that VolA is a canonical lipoprotein via mass spectrometry analysis and demonstrate the in vitro
49 46 in human IRF5 isoform 1), as evidenced by mass spectrometry analysis and detection with a phosphos
50 n studies with the OXA-24/40 enzyme, protein mass spectrometry analysis and docking studies allowed u
51 -Perchloric acid-soluble protein) by shotgun mass spectrometry analysis and gene identification, and
54 onstrated using liquid chromatography-tandem mass spectrometry analysis, and a total of 106 S-sulfhyd
55 vitro reconstruction of CTD phosphorylation, mass spectrometry analysis, and chromatin immunoprecipit
56 luding EV isolation, PTM/peptide enrichment, mass spectrometry analysis, and data quantification.
57 hromatography-electrospray ionization-tandem mass spectrometry analysis, and enzyme kinetic studies u
58 captured protein, tryptic digestion, tandem mass spectrometry analysis, and label-free quantificatio
59 he key events (sample desorption/ionization, mass spectrometry analysis, and sample translation) nece
60 ers are additionally acetylated, as shown by mass spectrometry analysis, and their binding to PARP-1
61 se 1 and 2 (PYCR1, PYCR2) were identified by mass spectrometry analysis as components of RRM2B comple
64 protein identification and quantification in mass spectrometry analysis by blocking peptide amino gro
65 he GC-O/FID system with GCxGC-time-of-flight mass spectrometry analysis by means of retention indices
66 of biological extracts coupled to precision mass spectrometry analysis (chromatographic fractionatio
67 data from top-down and bottom-up proteomics mass spectrometry analysis combined with NEM labeling re
71 ion experiments in liquid media coupled with mass spectrometry analysis confirmed that biogenic cyani
73 spectroscopy and hydrogen/deuterium exchange mass spectrometry analysis coupled to activity assays re
79 yrosine phosphatase PTPN14 was identified by mass spectrometry analysis exclusively in co-immunopreci
82 ed GC-IRMS (gas chromatography-isotope-ratio mass-spectrometry) analysis for carbon and nitrogen isot
86 drop of whole blood using gas chromatography-mass spectrometry analysis (GC-MS) of their per-O-methyl
88 labeling of surface residues, combined with mass spectrometry analysis, has increasingly played an i
100 CIEF immunoassay and immunoprecipitation mass spectrometry analysis identified peptides starting
101 key pathways affected by ATG treatment, and mass spectrometry analysis identified protein phosphatas
108 strains by liquid chromatography, coupled to mass spectrometry analysis, identified a total of 2161 p
109 psilon is acetylated, which was confirmed by mass spectrometry analysis, identifying 4 acetylated lys
119 degradation of cartilage was detected using mass spectrometry analysis (liquid chromatography-tandem
120 and multimodal liquid chromatography-tandem mass spectrometry analysis of >330,000 synthetic tryptic
121 archaeological pottery based on accelerator mass spectrometry analysis of (14)C in absorbed food res
124 vides a solution to the problem of real-time mass spectrometry analysis of a three-dimensional object
126 s were quantified through gas chromatography/mass spectrometry analysis of adsorbent samples collecte
127 s was accomplished by the comparative tandem mass spectrometry analysis of authentic TA derivatives f
128 extraction method for the Gas Chromatography-Mass Spectrometry analysis of blackberry (Rubus sp.) vol
130 lly restricted enzymatic tagging followed by mass spectrometry analysis of Caenorhabditis elegans inf
133 CI) source was developed that allowed direct mass spectrometry analysis of complex mixtures at a samp
137 hromatography electrospray ionization tandem mass spectrometry analysis of eighteen water-soluble art
139 cattering imaging of single living cells and mass spectrometry analysis of extracted lipids, we repor
144 rdeum vulgare) plants and gas chromatography-mass spectrometry analysis of free amino acids and liqui
145 have not been investigated in ADPKD yet, and mass spectrometry analysis of Gb4Cer from tissue extract
148 l adenocarcinoma (PDAC), we performed tandem mass spectrometry analysis of HLA class I-bound peptides
150 n was confirmed by coimmunoprecipitation and mass spectrometry analysis of immunoprecipitation produc
151 We extend this approach with large-scale mass spectrometry analysis of immunoprecipitations of 50
155 core components, based on cross-linking and mass spectrometry analysis of isolated, functional intac
162 tease, (5) liquid chromatography with tandem mass spectrometry analysis of O-GalNAc glycopeptides, (6
167 has been probed using liquid chromatography-mass spectrometry analysis of peptide-lipid mixtures.
169 led to accurate-mass, high-resolution tandem mass spectrometry analysis of peptides fractionated off-
172 uxes using a combined NMR/gas chromatography-mass spectrometry analysis of plasma following infusion
173 PLEKHA7 by yeast two-hybrid screening and by mass spectrometry analysis of PLEKHA7 immunoprecipitates
174 n of the seed followed by gas chromatography-mass spectrometry analysis of polar metabolites also rev
175 vidence from immunolabel, RNA expression and mass spectrometry analysis of postmortem samples that hu
176 d RT-qPCR, Western blot, flow cytometry, and mass spectrometry analysis of precisely dissected NR-lab
177 e new method demonstrates utility for native mass spectrometry analysis of proteins and G-quadruplex
180 f free amino acids and liquid chromatography-mass spectrometry analysis of proteins to track the enri
186 re profiled via liquid chromatography tandem mass spectrometry analysis of serum from 161 patients wi
187 on-chromatography coupled to high resolution mass spectrometry analysis of the 105 samples did not sh
191 sis with a phosphoprotein-specific stain and mass spectrometry analysis of the enriched phosphoprotei
194 validated using hydrogen-deuterium-exchange mass spectrometry analysis of the full-length protein an
195 trolysis experiments, gas chromatography and mass spectrometry analysis of the headspace in the elect
198 thods and allows for a successful downstream mass spectrometry analysis of the reaction products.
199 eration sequencing and liquid chromatography-mass spectrometry analysis of the secretomes of encapsul
200 ted clickable NAD(+) precursor, quantitative mass spectrometry analysis of the two probes in MDA-MB-2
204 netic defect that causes this disorder using mass spectrometry analysis of urine, bile, and serum sam
205 a tubular furnace and subsequent ICP-MS (ICP Mass Spectrometry) analysis of the obtained residues all
206 n based technique that enables the direct-to-mass-spectrometry analysis of extracted compounds via th
207 ombination with liquid chromatography/tandem mass spectrometry analysis, of which 22 exhibited signif
208 r cross-linking were distinguished by tandem mass spectrometry analysis on fibers seeded from solutio
209 uid chromatography-mass spectrometry, tandem mass spectrometry analysis on individual arterial sample
210 e retrocycloaddition reaction as revealed by mass spectrometry analysis on quasi-enantiomeric pyrroli
211 Liquid chromatography-mass spectrometry/mass spectrometry analysis on the tryptic peptide fragme
213 nserine, as confirmed by chromatographic and mass spectrometry analysis, rat UPF0586 was more active
214 bled the complex formed in vivo Ion mobility-mass spectrometry analysis resulted in an observed mass
223 A coimmunoprecipitation assay followed by mass spectrometry analysis revealed that dCRY interacts
225 ase-associated mutations, lectin binding and mass spectrometry analysis revealed that GNE deficiency
227 target protein was purified, and subsequent mass spectrometry analysis revealed that Mup44 is the cy
232 raperitoneal (IP) administration of SBI-425, mass spectrometry analysis revealed that the SBI-425 doe
236 YFP followed by liquid chromatography-tandem mass spectrometry analysis revealed the presence of prot
240 ure of gammaTuRC, combined with crosslinking mass spectrometry analysis, reveals an asymmetric confor
242 0 kDa on SDS-PAGE and did not contain Gbeta5 Mass spectrometry analysis showed no other proteins to b
243 Site-directed mutagenesis combined with mass spectrometry analysis showed that a disulfide bridg
252 -layer chromatography and gas chromatography-mass spectrometry analysis suggested the presence of ars
256 , and host-host protein interactions using a mass spectrometry analysis that takes just a few hours.
257 d by in vitro nuclear magnetic resonance and mass spectrometry analysis to assess intramyocardial lip
258 th its interactors, which were identified by mass spectrometry analysis to be mainly photosystem II a
259 sing laser capture methodology, we performed mass spectrometry analysis to compare T and NT protein e
261 tudy, we performed affinity purification and mass spectrometry analysis to explore protein-protein in
262 applied chemical cross-linking coupled with mass spectrometry analysis to gain insight into interact
263 AGE gel and isolated bands are submitted for mass spectrometry analysis to identify drug targets.
265 s multiple dimensions of separation prior to mass spectrometry analysis to reduce sample complexity a
267 wn assays, with GGGGCC5, in conjunction with mass spectrometry analysis, to identify candidate bindin
270 hly sensitive ( approximately 0.6 zeptomole) mass spectrometry analysis using minimal sample (18 pl p
271 ed a substrate trapping mutant combined with mass spectrometry analysis using Stable Isotope Labellin
273 ure followed by liquid chromatography tandem mass spectrometry analysis was implemented and validated
280 olecular genetics, analytical chemistry, and mass spectrometry analysis, we demonstrated that GAC bio
281 nosine (dG) and liquid chromatography-tandem mass spectrometry analysis, we demonstrated unambiguousl
282 Using high-performance liquid chromatography-mass spectrometry analysis, we detected these flavonoids
285 Using affinity RNA pull-down followed by mass spectrometry analysis, we found two RNA-binding pro
286 matrix-assisted laser desorption ionization mass spectrometry analysis, we here identify a key compo
291 (15)N2 tracer experiments and isotope ratio mass spectrometry analysis, we observed that seep N2 fix
292 ered lacticin 481 biosynthetic machinery and mass spectrometry analysis, we show here that the LctA l
293 ng an FGFR1c-specific antibody together with mass spectrometry analysis, we show that RPTECs express
294 oupled with nanoliquid chromatography-tandem mass spectrometry analysis, we show that the in planta m
297 ciated peptides during liquid chromatography-mass spectrometry analysis, which can easily be misident
298 sotope-dilution liquid chromatography-tandem mass spectrometry analysis, which can serve as a general
300 An autonomous metabolomic workflow combining mass spectrometry analysis with tandem mass spectrometry